109 Canberra Avenue Development Redwin Pty Limited

Status: Registered
Australian Company Number: 165298653
Australian Business Number: 23165298653
Registration date: 14th August 2013
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated


109 Canberra Avenue Development Redwin Pty Limited is a limited by shares Australian proprietary company. Located at ACT 2600 since 2016-12-06 the company is, as the updated on 2016-12-06 ABN database shows, registered. Known company numbers for 109 Canberra Avenue Development Redwin Pty Limited are as follows: ACN - 165298653, Australian Business Number - 23165298653. This Australian proprietary company was previously located in ACT 2604 (from 2014-09-25 to 2016-12-06), ACT 2604 (from 2014-04-24 to 2014-09-25), ACT 2604 (from 2013-08-14 to 2014-04-24).


Details for ABN 23165298653

Type: Australian Private Company

ABN Status

Status From To
Active 14th August 2013 current

Main Name

Name From To
109 Canberra Avenue Development Redwin Pty Limited 14th August 2013 current

Main Location

Location From To
ACT 2600 6th December 2016 current
ACT 2604 25th September 2014 6th December 2016
ACT 2604 24th April 2014 25th September 2014
ACT 2604 14th August 2013 24th April 2014


Find company

ACT 2600 Location

2018 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2018 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2018, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.